258 related articles for article (PubMed ID: 17210773)
1. In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococci.
Livermore DM; Warner M; Mushtaq S; North S; Woodford N
Antimicrob Agents Chemother; 2007 Mar; 51(3):1112-4. PubMed ID: 17210773
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of Staphylococcus aureus and Enterococcus faecalis mutants with reduced susceptibility to the investigational oxazolidinone RWJ-416457.
Santoro CM; Bush K; Abbanat D
Int J Antimicrob Agents; 2010 Nov; 36(5):424-9. PubMed ID: 20846828
[TBL] [Abstract][Full Text] [Related]
3. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
Drago L; Nicola L; De Vecchi E
Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
[TBL] [Abstract][Full Text] [Related]
4. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
[TBL] [Abstract][Full Text] [Related]
5. Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci.
Livermore DM; Mushtaq S; Warner M; Woodford N
J Antimicrob Chemother; 2009 Apr; 63(4):713-5. PubMed ID: 19164418
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
[TBL] [Abstract][Full Text] [Related]
7. Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
Ntokou E; Stathopoulos C; Kristo I; Dimitroulia E; Labrou M; Vasdeki A; Makris D; Zakynthinos E; Tsakris A; Pournaras S
J Antimicrob Chemother; 2012 Aug; 67(8):1819-23. PubMed ID: 22532462
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium.
Rybak MJ; Cappelletty DM; Moldovan T; Aeschlimann JR; Kaatz GW
Antimicrob Agents Chemother; 1998 Mar; 42(3):721-4. PubMed ID: 9517963
[TBL] [Abstract][Full Text] [Related]
9. Comparative activity of linezolid against staphylococci and enterococci isolated in Italy.
Stefani S; Mezzatesta ML; Tempera G; Debbra E; Schito AM; Nicoletti G; Marchére A
Clin Microbiol Infect; 2002 Jun; 8(6):368-72. PubMed ID: 12084106
[TBL] [Abstract][Full Text] [Related]
10. A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin.
Wang Y; Lv Y; Cai J; Schwarz S; Cui L; Hu Z; Zhang R; Li J; Zhao Q; He T; Wang D; Wang Z; Shen Y; Li Y; Feßler AT; Wu C; Yu H; Deng X; Xia X; Shen J
J Antimicrob Chemother; 2015 Aug; 70(8):2182-90. PubMed ID: 25977397
[TBL] [Abstract][Full Text] [Related]
11. Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis.
Qi C; Zheng X; Obias A; Scheetz MH; Malczynski M; Warren JR
J Clin Microbiol; 2006 Mar; 44(3):1098-100. PubMed ID: 16517903
[TBL] [Abstract][Full Text] [Related]
12. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.
Johnson AP; Tysall L; Stockdale MV; Woodford N; Kaufmann ME; Warner M; Livermore DM; Asboth F; Allerberger FJ
Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):751-4. PubMed ID: 12415476
[TBL] [Abstract][Full Text] [Related]
13. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
Allen GP; Bierman BC
Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
[TBL] [Abstract][Full Text] [Related]
14. Linezolid-resistant enterococci in Greece: epidemiological characteristics.
Spiliopoulou I; Damani A; Chini V; Zerva L; Kolonitsiou F; Anastassiou ED; Petinaki E
Chemotherapy; 2011; 57(3):181-5. PubMed ID: 21474928
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.
Johnson AP; Warner M; Livermore DM
J Antimicrob Chemother; 2002 Jul; 50(1):89-93. PubMed ID: 12096011
[TBL] [Abstract][Full Text] [Related]
16. AM-7359--a novel oxazolidinone with low resistance potential and potent activity against drug resistant pathogens.
Overbye KM; Mordekhay D
J Chemother; 2007 Jun; 19(3):249-55. PubMed ID: 17594918
[TBL] [Abstract][Full Text] [Related]
17. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.
Bae HG; Sung H; Kim MN; Lee EJ; Koo Lee S
Scand J Infect Dis; 2006; 38(5):383-6. PubMed ID: 16709544
[TBL] [Abstract][Full Text] [Related]
18. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.
Marshall SH; Donskey CJ; Hutton-Thomas R; Salata RA; Rice LB
Antimicrob Agents Chemother; 2002 Oct; 46(10):3334-6. PubMed ID: 12234875
[TBL] [Abstract][Full Text] [Related]
19. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
Jones RN; Fritsche TR; Sader HS; Ross JE
Diagn Microbiol Infect Dis; 2007 Nov; 59(3):309-17. PubMed ID: 17720350
[TBL] [Abstract][Full Text] [Related]
20. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
Pillai SK; Sakoulas G; Wennersten C; Eliopoulos GM; Moellering RC; Ferraro MJ; Gold HS
J Infect Dis; 2002 Dec; 186(11):1603-7. PubMed ID: 12447736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
